Article info
PDFTherapeutics
Women's Health Initiative randomised ontrolled trial
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause
- Correspondence to S. Mitchell Harman
Kronos Longevity Research Institute, 2390 East Camelback, Ste 440, Phoenix, AZ 85015, USA; mitch.harman{at}kronosinstitute.org
Citation
Combined estrogen plus progestin may reduce coronary heart disease risk after 5 years of use in postmenopausal women starting treatment within 10 years of menopause
Publication history
- First published June 3, 2010.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions